Table 1.
Structure | Ki (nM) | EC50 (nM) | % stimulation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
MOR | DOR | KOR | MOR | DOR | KOR | MOR | DOR | KOR | ||
2 | 29±9 | 14±2 | 310±50 | dns | dns | dns | 11±6 | dns | dns | |
3 | 1.4±0.1 | 7.8±0.9 | 140±24 | dns | dns | dns | dns | dns | dns | |
4 | 2.0±0.8 | 12±2 | 110±11 | 119±39 | dns | dns | 26±2 | dns | dns | |
5 | 3.8±0.8 | 36±4 | 250±51 | 150±49 | dns | dns | 23±2 | dns | dns | |
6 | 1.1±0.3 | 6.6±2 | 78±15 | 85±10 | dns | dns | 17±3 | dns | dns | |
7 | 6.4±0.1 | 11±0.65 | 330±92 | dns | dns | dns | dns | dns | dns | |
8 | 1.1±0.2 | 21±7 | 150±42 | dns | dns | dns | dns | dns | dns | |
9 | 0.45±0.3 | 6.6±2 | 78±15 | 64±3 | dns | dns | 43±6 | dns | 12±1 | |
10 | 0.29±0.07 | 23±8.9 | 89±23 | 20±3.6 | dns | 1500±120 | 36±4 | dns | 16±3 | |
11 | 0.3±0.1 | 28±6.8 | 54±3.2 | 41±15 | dns | dns | 49±5 | dns | 11±7 | |
12 | 0.42±0.15 | 6.9±1.7 | 39±15 | 53±23 | dns | 660±80 | 42±1 | dns | 12±5 |
All values are expressed as the mean ± SEM of three separate assays performed in duplicate. dns: does not stimulate. Binding affinities (Ki) were obtained by competitive displacement of radiolabeled [3H]diprenorphine in membrane preparations. Efficacy data were obtained using agonist induced stimulation of [35S]GTPγS binding assay. Efficacy is represented as EC50 (nM) and percent maximal stimulation relative to standard agonist DAMGO (MOR), DPDPE (DOR), or U69,593 (KOR) at 10 µM.